3/13
12:08 pm
bsx
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Low
Report
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
3/13
09:00 am
bsx
BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit — The Gross Law Firm
Low
Report
BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit — The Gross Law Firm
3/12
08:35 pm
bsx
Why Boston Scientific (BSX) Dipped More Than Broader Market Today [Yahoo! Finance]
Low
Report
Why Boston Scientific (BSX) Dipped More Than Broader Market Today [Yahoo! Finance]
3/12
07:25 pm
bsx
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX
3/12
03:04 pm
bsx
Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Low
Report
Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
3/12
11:10 am
bsx
INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Low
Report
INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
3/12
09:05 am
bsx
BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
Low
Report
BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
3/12
09:00 am
bsx
BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt
Low
Report
BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt
3/12
08:24 am
bsx
BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
Low
Report
BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
3/12
03:45 am
bsx
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
Low
Report
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
3/11
02:21 pm
bsx
Deadline Approaching: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Low
Report
Deadline Approaching: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
3/11
12:00 pm
bsx
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
Low
Report
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
3/11
11:30 am
bsx
Boston Scientific (BSX) had its price target lowered by Citigroup Inc. from $102.00 to $94.00. They now have a "buy" rating on the stock.
Low
Report
Boston Scientific (BSX) had its price target lowered by Citigroup Inc. from $102.00 to $94.00. They now have a "buy" rating on the stock.
3/10
06:30 pm
bsx
BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Low
Report
BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
3/10
05:55 pm
bsx
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
Low
Report
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
3/10
04:00 pm
bsx
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Unsustainable U.S. Electrophysiology Segment Growth Rate: Levi & Korsinsky
Low
Report
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Unsustainable U.S. Electrophysiology Segment Growth Rate: Levi & Korsinsky
3/10
02:40 pm
bsx
INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead the Boston Scientific Class Action Lawsuit – RGRD Law
Low
Report
INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead the Boston Scientific Class Action Lawsuit – RGRD Law
3/10
12:05 pm
bsx
Law Offices of Frank R. Cruz Encourages Boston Scientific Corporation (BSX) Shareholders To Inquire About Securities Fraud Class Action
Low
Report
Law Offices of Frank R. Cruz Encourages Boston Scientific Corporation (BSX) Shareholders To Inquire About Securities Fraud Class Action
3/10
09:08 am
bsx
Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims
Low
Report
Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims
3/10
09:00 am
bsx
Class Action Filed Against Boston Scientific Corporation (BSX) - May 4, 2026 Deadline to Join - Contact The Gross Law Firm
Low
Report
Class Action Filed Against Boston Scientific Corporation (BSX) - May 4, 2026 Deadline to Join - Contact The Gross Law Firm
3/10
09:00 am
bsx
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors
Medium
Report
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors
3/10
08:27 am
bsx
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
Low
Report
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
3/9
04:00 pm
bsx
Shareholders of Boston Scientific Corporation Should Contact Levi & Korsinsky Before May 4, 2026 to Discuss Your Rights – BSX
Low
Report
Shareholders of Boston Scientific Corporation Should Contact Levi & Korsinsky Before May 4, 2026 to Discuss Your Rights – BSX
3/9
12:23 pm
bsx
BSX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Boston Scientific Corporation Class Action Lawsuit
Low
Report
BSX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Boston Scientific Corporation Class Action Lawsuit
3/9
09:00 am
bsx
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Boston Scientific Corporation (BSX) Shareholders to Inquire About Securities Fraud Class Action
Low
Report
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Boston Scientific Corporation (BSX) Shareholders to Inquire About Securities Fraud Class Action